Financial Ratios

SAAMYA BIOTECH (INDIA) LTD.

NSE : NABSE : 532905ISIN CODE : INE320H01019Industry : Pharmaceuticals & DrugsHouse : Private
BSE1.970 (0 %)
PREV CLOSE ( ) 1.97
OPEN PRICE ( ) 1.97
BID PRICE (QTY) 0.00 (0)
OFFER PRICE (QTY) 0.00 (0)
VOLUME 1005
TODAY'S LOW / HIGH ( )1.97 2.07
52 WK LOW / HIGH ( ) 1.972.07
NSE
This Company is not listed in NSE
Select year
ParticularsMar2016Mar2015Mar2014Mar2013Mar2012
Operational & Financial Ratios
   Earnings Per Share (Rs)-0.18-0.270.04-0.160.11
   CEPS(Rs)0.190.130.09-0.130.14
   DPS(Rs)0.000.000.000.000.00
   Book NAV/Share(Rs)11.3511.5311.8011.7611.92
   Tax Rate(%)52.967.3737.491.6021.28
Margin Ratios
   Core EBITDA Margin(%)-0.860.792.02-10.292.48
   EBIT Margin(%)-6.19-2.421.21-12.695.02
   Pre Tax Margin(%)-6.20-2.431.09-13.631.52
   PAT Margin (%)-2.92-2.250.68-13.411.20
   Cash Profit Margin (%)3.151.051.52-11.011.51
Performance Ratios
   ROA(%)-0.58-1.160.20-0.770.62
   ROE(%)-1.55-2.340.33-1.361.05
   ROCE(%)-2.93-2.220.50-1.113.54
   Asset Turnover(x)0.200.510.290.060.51
   Sales/Fixed Asset(x)1.292.522.061.8615.26
   Working Capital/Sales(x)5.019.363.890.977.30
Efficiency Ratios
   Fixed Capital/Sales(x)0.780.400.490.540.07
   Receivable days1126.58340.37444.562409.01207.89
   Inventory Days0.000.000.000.000.00
   Payable days1100.53320.65409.852246.25198.83
Valuation Parameters
   PER(x)0.000.0029.760.0029.55
   PCE(x)22.0821.5613.27-11.4423.47
   Price/Book(x)0.370.240.100.130.28
   Yield(%)0.000.000.000.000.00
   EV/Net Sales(x)0.950.360.541.370.37
   EV/Core EBITDA(x)-773.6839.6225.15-13.356.91
   EV/EBIT(x)-14.69-14.2842.71-10.827.33
   EV/CE(x)0.170.140.160.080.17
   M Cap / Sales0.730.240.211.260.36
Growth Ratio
   Net Sales Growth(%)-49.94115.31347.99-87.0741.65
   Core EBITDA Growth(%)-106.73-8.39193.89-124.72309.17
   EBIT Growth(%)-27.79-531.53144.84-132.37404.92
   PAT Growth(%)35.01-812.06123.84-243.51215.90
   EPS Growth(%)35.01-812.06123.84-243.51193.19
Financial Stability Ratios
   Total Debt/Equity(x)0.110.130.150.010.01
   Current Ratio(x)1.061.081.341.161.19
   Quick Ratio(x)1.061.081.341.161.19
   Interest Cover(x)-399.67-1153.539.89-13.491.43
   Total Debt/Mcap(x)0.310.531.560.090.05

© NIRMAL BANG. All rights reserved

Designed , Developed & Content Powered by Accord Fintech Pvt. Ltd.

Open an Account
FOR AFREE *DEMAT & BROKING ACCOUNT

Please fill in the details below

Close X

(Note - You will receive a call from our sales executive)

CLOSE X

RISK DISCLOSURES ON DERIVATIVES

  • 9 out of 10 individual traders in equity Futures and Options Segment, incurred net losses.
  • On an average, loss makers registered net trading loss close to ₹ 50,000.
  • Over and above the net trading losses incurred, loss makers expended an additional 28% of net trading losses as transaction costs.
  • Those making net trading profits, incurred between 15% to 50% of such profits as transaction cost.

Source:

1. SEBI study dated January 25, 2023 on “Analysis of Profit and Loss of Individual Traders dealing in equity Futures and Options (F&O) Segment”, wherein Aggregate Level findings are based on annual Profit/Loss incurred by individual traders in equity F&O during FY 2021-22.